$1.000
+0.003 (+0.35%)收盘时
SEED 资讯
SEED 事件
Origin Agritech Unveils Southwest R&D Center in Guiyang
Origin Agritech unveiled its Southwest R&D Center in Kaiyang County, Guiyang City, Guizhou Province, on the second anniversary of the company's relaunch. The center is anchored by two entities established earlier this year: Guizhou Origin Biotechnology, a wholly owned subsidiary, and Guiyang Agricultural Investment Origin Modern Seed Industry, a state-controlled company in which Origin holds a 25% equity interest. Together, they span research, propagation, promotion, and commercialization across the Southwest region. The approximately 8,000-square-meter complex houses a 4,000-square-meter experimental zone, a 600-square-meter molecular testing platform, a 2,000-square-meter tissue culture platform, and four intelligent glass greenhouses totaling more than 15,000 square meters, supported by roughly 160 mu of standardized field trial land. This facility is part of Guizhou Origin, a research company wholly owned by Origin. It stands as one of the company's four research stations and is currently the largest in terms of floor space. With its infrastructure, it is poised to become the most significant biotech research center in China. Notably, Guizhou Origin supports Origin's biotech operations nationwide, whereas the joint venture is dedicated to serving businesses in southwest China.
Origin Agritech Secures Exclusive Rights to Zhongdan 6202
Origin Agritech announced that it has secured exclusive nationwide rights to Zhongdan 6202, the flagship early-maturing corn hybrid developed under China's National Key Research and Development Program of the 14th Five-Year Plan. Under the agreement signed with the Institute of Crop Sciences of the Chinese Academy of Agricultural Sciences, Origin Agritech holds exclusive rights across the full commercial chain - seed production, sales and marketing, demonstration promotion, and intellectual property enforcement - for a variety that carries national registration approval and three consecutive years of national trial data behind it.
Origin Agritech Appoints Jian Zhang as Independent Director
Origin Agritech announced the appointment of Jian Zhang as an independent member of its Board of Directors and the reappointment of Zheng James Chen as CFO. Both appointments are effective March 20. Chen has served Origin in multiple senior capacities over more than a decade, including two separate tenures as CFO and one as CEO. Changqing Mao resigned from his position as independent director, effective March 12, due to new professional commitments. Chi Kin Cheng resigned as CFO, effective March 19, for personal development reasons. Zhang currently serves as CEO of ChinaAg JiaNuo Seed Science and Technology . He previously served as CTO of Syngenta Group China Seed Business and as Director of the National Center of Technology Innovation for Maize. Chen rejoins Origin having previously served as the company's CFO from January 2012 to January 2016, CEO from February 2018 to December 2018, and CFO again from December 2018 to April 2020. He also served as a member of Origin's Board of Directors from August 2017 to April 2020. Prior to rejoining Origin, Chen served as Chairman of the Board and CEO of China Finance Online and as CFO of Yunji.
Origin Agritech Enters Patent Licensing Agreement with Shandong for Cas-SF01
Origin Agritech announced it has entered into a patent license agreement with Shandong Shunfeng Biotechnology for the Cas-SF01 gene editing tool. This collaboration grants Origin long-term access to fully IP-protected gene editing technologies, providing a solid foundation for the Company's future research and development in trait gene editing. It also aims to accelerate the adoption of advanced gene editing technologies in corn breeding, marking a significant milestone in Origin's efforts to develop high-density, high-yield, and adaptable corn varieties. Origin Agritech has initiated the biosafety assessment process for the edited lines. Additionally, this license agreement provides a substantial advantage by facilitating biosafety approval for Origin's current and future gene editing transformants utilizing Hi-3 one-step gene-editing method, for some of which the Company has already applied. The Company estimates obtaining final biosafety certification will require 1-2 years due to regulatory procedures and experimental timelines. Origin is committed to advancing this process and accelerating the commercialization of its gene editing innovations.
Origin Agritech Reveals Significant Achievements
Origin Agritech announced a series of major milestones designed to enhance its operational capabilities, strengthen its market position, and advance its long-term growth strategy. Origin Agritech has received a new crop seed production and operation license from the Beijing Municipal Bureau of Agriculture and Rural Affairs, authorizing the Company to produce, process, package, wholesale, and retail corn seeds. This license represents a significant step forward in expanding Origin's production capacity and operational infrastructure. With this approval, Origin now holds two crop seed production and operation licenses in China -the other being held by its subsidiary Xinjiang OriginBio Seed Limited - enabling a broader regional footprint and greater revenue diversification across complementary markets. Additionally, the Beijing Tongzhou District Market Supervision Administration has formally approved the inclusion of genetically modified crop seed production in the Company's business scope. In parallel, Origin has increased the registered capital of its subsidiary Beijing Origin Seed from RMB 30M, or $4.2M, to RMB 100M, or $14M. The Company has also completed a strategic restructuring, consolidating its key production and sales entities - including Xinjiang Originbo Seed Limited - under Beijing Origin. This integration establishes Beijing Origin as the Company's primary operational hub, enhancing efficiency and supporting future scalability.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。